Core Viewpoint - Rosen Law Firm is reminding investors who purchased PomDoctor Ltd. securities between October 9, 2025, and December 11, 2025, of the April 7, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought PomDoctor securities during the specified period may be eligible for compensation without any out-of-pocket costs through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. - The deadline to move the Court to serve as lead plaintiff is April 7, 2026, with the lead plaintiff representing other class members in the litigation [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3]. Group 3: Case Allegations - The lawsuit alleges that PomDoctor made false or misleading statements and failed to disclose critical information, including involvement in a fraudulent stock promotion scheme and insider trading activities [4]. - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, and that PomDoctor's public statements omitted mention of false rumors and artificial trading activity [4]. - As a result of these actions, the positive statements made by PomDoctor regarding its business and prospects were materially misleading [4].